Connection

Kelly Hunt to Risk

This is a "connection" page, showing publications Kelly Hunt has written about Risk.
Connection Strength

0.035
  1. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA. 2011 May 11; 305(18):1873-81.
    View in: PubMed
    Score: 0.021
  2. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004 Nov; 27(11):2676-81.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.